EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials

Siddharth Agarwal iD, Christopher W Beard iD, Jagjit Khosla iD, Shari Clifton iD, Muhammad Faraz Anwaar iD, Asad Ghani iD, Kassem Farhat iD, Nikolaos Pyrpyris iD, Joud Momani iD, Muhammad Bilal Munir iD, Christopher V DeSimone, Abhishek Deshmukh iD und 4 weitere

Europace · 04.07.2023 · 25 (7)

DOI: 10.1093/europace/euad169 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Europace, online erschienen am 21.06.2023. Verfasst von Siddharth Agarwal und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L Young Blvd, Oklahoma City, OK, 73104, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiac Surgical Procedures. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Education Research, Academy of Teaching Scholars University of Oklahoma College of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Colchicine is an anti-inflammatory drug that may prevent post-operative atrial fibrillation (POAF). The effect of this drug has been inconsistently shown in previous clinical trials. We aimed to compare the efficacy and safety of colchicine vs. placebo to prevent POAF in patients undergoing cardiac surgery. Methods and results A systematic search of EMBASE, MEDLINE, SCOPUS, ClinicalTrials.gov, and the Cochrane Library for randomized controlled trials (RCTs) was conducted from inception till April 2023. The primary outcome was the incidence of POAF after any cardiac surgery. The secondary outcome was the rate of drug discontinuation due to adverse events and adverse gastrointestinal events. Risk ratios (RR) were reported using the Mantel Haenszel method. A total of eight RCTs comprising 1885 patients were included. There was a statistically significant lower risk of developing POAF with colchicine vs. placebo (RR: 0.70; 95% CI: 0.59–0.82; P < 0.01, I2 = 0%), and this effect persisted across different subgroups. There was a significantly higher risk of adverse gastrointestinal events (RR: 2.20; 95% CI: 1.38–3.51; P < 0.01, I2 = 55%) with no difference in the risk of drug discontinuation in patients receiving colchicine vs. placebo (RR: 1.33; 95% CI: 0.93–1.89; P = 0.11, I2 = 0%). Conclusion This meta-analysis of eight RCTs shows that colchicine is effective at preventing POAF, with a significantly higher risk of adverse gastrointestinal events but no difference in the rate of drug discontinuation. Future studies are required to define the optimal duration and dose of colchicine for the prevention of POAF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiac Surgical ProceduresHumansColchicineRandomized Controlled Trials as TopicIncidence

Stichwörter der Autor:innen

Atrial fibrillationColchicineMeta-analysisOutcomes

Substanzen

Colchicine

Autor:innen und Institutionen

  • Department of Medicine, University of Oklahoma Health Sciences Center, 800 Stanton L Young Blvd, Oklahoma City, OK, 73104, USA.
  • Robert M Bird Health Sciences Library, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Department of Internal Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Division of Cardiovascular Medicine, University of California Davis, Sacramento, CA, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

ORCID-Profile: Siddharth Agarwal, Christopher W Beard, Jagjit Khosla, Shari Clifton, Muhammad Faraz Anwaar, Asad Ghani, Kassem Farhat, Nikolaos Pyrpyris, Joud Momani, Muhammad Bilal Munir, Abhishek Deshmukh, Stavros Stavrakis, Sunny Po, Zain Ul Abideen Asad

Förderung

  • Education Research
  • Academy of Teaching Scholars University of Oklahoma College of Medicine

Zitieren

APA

Agarwal, S., Beard, C. W., Khosla, J., Clifton, S., Anwaar, M. F., Ghani, A., Farhat, K., Pyrpyris, N., Momani, J., Munir, M. B., DeSimone, C. V., Deshmukh, A., Stavrakis, S., Jackman, W. M., Po, S., & Asad, Z. U. A. (2023). Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Europace, 25(7). https://doi.org/10.1093/europace/euad169

Vancouver

Agarwal S, Beard CW, Khosla J, Clifton S, Anwaar MF, Ghani A, et al. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Europace. 2023;25(7). doi:10.1093/europace/euad169

BibTeX
@article{Agarwal2023,
  author = {Agarwal, Siddharth and Beard, Christopher W and Khosla, Jagjit and Clifton, Shari and Anwaar, Muhammad Faraz and Ghani, Asad and Farhat, Kassem and Pyrpyris, Nikolaos and Momani, Joud and Munir, Muhammad Bilal and DeSimone, Christopher V and Deshmukh, Abhishek and Stavrakis, Stavros and Jackman, Warren M and Po, Sunny and Asad, Zain Ul Abideen},
  title = {Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials},
  journal = {Europace},
  year = {2023},
  volume = {25},
  number = {7},
  doi = {10.1093/europace/euad169}
}
Kostenlos starten →